POMC and obesity due to melanocortin 4 receptor deficiency: Our data could suggest that there is potential to exploit the naturally occurring POMC-derived peptides to treat obesity and type-2 diabetes, but this relies on first understanding the specific function(s) for desacetyl-α-MSH and α-MSH in the brain and the periphery.